Category: Approval/Launch Region: North America · United States Company: Pfizer Inc

Beximco Pharma introduces generic version of Pfizers Paxlovid the first US FDA approved oral therapy for Covid-19 treatment

Beximco Pharma introduces generic version of Pfizers Paxlovid the first US FDA approved oral therapy for Covid-19 treatment
Beximco Pharmaceuticals Limited, the fast-growing manufacturer of generic pharmaceutical products and APIs, announced the launch of the world's first generic version of Pfizer

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!